APA (7th ed.) Citation

Gluz, O., Nitz, U. A., Christgen, M., Kates, R. E., Shak, S., Clemens, M., . . . Harbeck, N. (2016). West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment. Journal of clinical oncology, 34(20), 2341-2349. https://doi.org/10.1200/JCO.2015.63.5383

Chicago Style (17th ed.) Citation

Gluz, Oleg, et al. "West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment." Journal of Clinical Oncology 34, no. 20 (2016): 2341-2349. https://doi.org/10.1200/JCO.2015.63.5383.

MLA (9th ed.) Citation

Gluz, Oleg, et al. "West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment." Journal of Clinical Oncology, vol. 34, no. 20, 2016, pp. 2341-2349, https://doi.org/10.1200/JCO.2015.63.5383.